BioNTech SE (BNTX) Non-Current Assets (2018 - 2025)

BioNTech SE (BNTX) reported Non-Current Assets of $6.8 billion for Q4 2025, up 70.79% on a YoY basis from $4.0 billion in Q4 2024, and up 5.56% sequentially from $6.4 billion in Q3 2025.

BioNTech SE (BNTX) Non-Current Assets (2018 - 2025) Analysis & Trends

BioNTech SE (BNTX) has 8 years of Non-Current Assets data on file, last reported at $6.8 billion in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 70.79% year-over-year to $6.8 billion; the trailing twelve-month figure through Dec 2025 stood at $25.5 billion (up 51.46% YoY), and the FY2025 full-year result was $6.6 billion, up 65.76% from the prior year.
  • Non-Current Assets climbed to $6.8 billion in Q4 2025, from $6.4 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $6.8 billion in Q4 2025 to a low of $803.3 million in Q3 2021.
  • A 5-year average of $3.2 billion and a median of $3.5 billion in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets soared 224.44% in 2023 and gained 6.37% in 2024, its largest moves.
  • Tracing BNTX's Non-Current Assets over 5 years: stood at $867.7 million in 2021, then jumped by 59.57% to $1.4 billion in 2022, then surged by 170.35% to $3.7 billion in 2023, then rose by 6.37% to $4.0 billion in 2024, then soared by 70.79% to $6.8 billion in 2025.
  • Business Quant data shows BNTX's Non-Current Assets at $6.8 billion in Q4 2025, $6.4 billion in Q3 2025, and $6.5 billion in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 BioNTech SE 22.13 Bn 22.13 Bn 668.28 Mn 6.80 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.80 Bn
Sep 30, 2025 6.44 Bn
Jun 30, 2025 6.46 Bn
Mar 31, 2025 5.85 Bn
Dec 31, 2024 3.98 Bn
Sep 30, 2024 4.30 Bn
Jun 30, 2024 4.26 Bn
Mar 31, 2024 4.33 Bn
Dec 31, 2023 3.74 Bn
Sep 30, 2023 3.76 Bn
Jun 30, 2023 3.28 Bn
Mar 31, 2023 2.14 Bn
Dec 31, 2022 1.38 Bn
Sep 30, 2022 1.40 Bn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 935.47 Mn
Dec 31, 2021 867.70 Mn
Sep 30, 2021 803.33 Mn
Jun 30, 2021 854.19 Mn
Mar 31, 2021 806.61 Mn